Genentech's Immunology/Infectious Disease Deal Maker On Following The Science

 
• By Jo Shorthouse
  
Miniature people
Genentech had been closely monitoring the microbiome space for “at least four years” before a deal was struck • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business